Cargando…
Percutaneous Transforaminal Endoscopic Surgery (PTES) for Treatment of Lumbar Degenerative Disease in Patients with Underlying Diseases: A Retrospective Cohort Study of 196 Cases
OBJECTIVE: To evaluate the postoperative outcomes, safety and feasibility of percutaneous transforaminal endoscopic surgery (PTES) for the treatment of lumbar degenerative disease (LDD) in the patients with underlying diseases. METHODS: From June 2017 to April 2019, PTES was performed to treat 226 p...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10072145/ https://www.ncbi.nlm.nih.gov/pubmed/37025953 http://dx.doi.org/10.2147/JPR.S396993 |
_version_ | 1785019321970327552 |
---|---|
author | Zhou, Tianyao Ma, Tianle Gu, Yutong Zhang, Liang Che, Wu Wang, Yichao |
author_facet | Zhou, Tianyao Ma, Tianle Gu, Yutong Zhang, Liang Che, Wu Wang, Yichao |
author_sort | Zhou, Tianyao |
collection | PubMed |
description | OBJECTIVE: To evaluate the postoperative outcomes, safety and feasibility of percutaneous transforaminal endoscopic surgery (PTES) for the treatment of lumbar degenerative disease (LDD) in the patients with underlying diseases. METHODS: From June 2017 to April 2019, PTES was performed to treat 226 patients of single-level LDD. According to clinical background, the patients were divided into two groups. A total of 102 patients with underlying diseases were included in group A. The other 124 LDD patients without underlying diseases were included in group B. The occurrence of postoperative complications was recorded. Leg pain was assessed before, immediately, 1 month, 2 months, 3 months, 6 months, 1 year, and 2 years after PTES using VAS, and ODI before PTES and 2 years after PTES were recorded. The therapeutic quality (Excellent, Good, Moderate or Poor) was defined according to MacNab grade at 2-year follow-up. RESULTS: No aggravation of underlying diseases or serious complications was observed in all patients within 6 months after the operation. Altogether, 196 patients were followed up for more than 2 years, 89 patients in group A and 107 patients in group B. The VAS score of leg pain and ODI dropped significantly after surgery (P<0.001) in both groups. One case of group B received PTES again due to recurrence 52 months after surgery. According to MacNab, the excellent and good rate was 97.75% (87/89) in group A and 96.26% (103/107) in group B. In operative duration, frequency of intraoperative fluoroscopy, blood loss, incision length, hospital stay, VAS, ODI, and the excellent and good rate, there was no statistical difference between the two groups. CONCLUSION: PTES is safe, effective and feasible for the treatment of LDD with underlying diseases, which is comparable to PTES for LDD without underlying diseases. The entrance point of PTES (Gu’s Point) is located at the corner of the flat back turning to the lateral side. PTES is not only a minimally invasive surgical technique but also includes a postoperative care system for preventing LDD recurrence. |
format | Online Article Text |
id | pubmed-10072145 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-100721452023-04-05 Percutaneous Transforaminal Endoscopic Surgery (PTES) for Treatment of Lumbar Degenerative Disease in Patients with Underlying Diseases: A Retrospective Cohort Study of 196 Cases Zhou, Tianyao Ma, Tianle Gu, Yutong Zhang, Liang Che, Wu Wang, Yichao J Pain Res Original Research OBJECTIVE: To evaluate the postoperative outcomes, safety and feasibility of percutaneous transforaminal endoscopic surgery (PTES) for the treatment of lumbar degenerative disease (LDD) in the patients with underlying diseases. METHODS: From June 2017 to April 2019, PTES was performed to treat 226 patients of single-level LDD. According to clinical background, the patients were divided into two groups. A total of 102 patients with underlying diseases were included in group A. The other 124 LDD patients without underlying diseases were included in group B. The occurrence of postoperative complications was recorded. Leg pain was assessed before, immediately, 1 month, 2 months, 3 months, 6 months, 1 year, and 2 years after PTES using VAS, and ODI before PTES and 2 years after PTES were recorded. The therapeutic quality (Excellent, Good, Moderate or Poor) was defined according to MacNab grade at 2-year follow-up. RESULTS: No aggravation of underlying diseases or serious complications was observed in all patients within 6 months after the operation. Altogether, 196 patients were followed up for more than 2 years, 89 patients in group A and 107 patients in group B. The VAS score of leg pain and ODI dropped significantly after surgery (P<0.001) in both groups. One case of group B received PTES again due to recurrence 52 months after surgery. According to MacNab, the excellent and good rate was 97.75% (87/89) in group A and 96.26% (103/107) in group B. In operative duration, frequency of intraoperative fluoroscopy, blood loss, incision length, hospital stay, VAS, ODI, and the excellent and good rate, there was no statistical difference between the two groups. CONCLUSION: PTES is safe, effective and feasible for the treatment of LDD with underlying diseases, which is comparable to PTES for LDD without underlying diseases. The entrance point of PTES (Gu’s Point) is located at the corner of the flat back turning to the lateral side. PTES is not only a minimally invasive surgical technique but also includes a postoperative care system for preventing LDD recurrence. Dove 2023-03-31 /pmc/articles/PMC10072145/ /pubmed/37025953 http://dx.doi.org/10.2147/JPR.S396993 Text en © 2023 Zhou et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Zhou, Tianyao Ma, Tianle Gu, Yutong Zhang, Liang Che, Wu Wang, Yichao Percutaneous Transforaminal Endoscopic Surgery (PTES) for Treatment of Lumbar Degenerative Disease in Patients with Underlying Diseases: A Retrospective Cohort Study of 196 Cases |
title | Percutaneous Transforaminal Endoscopic Surgery (PTES) for Treatment of Lumbar Degenerative Disease in Patients with Underlying Diseases: A Retrospective Cohort Study of 196 Cases |
title_full | Percutaneous Transforaminal Endoscopic Surgery (PTES) for Treatment of Lumbar Degenerative Disease in Patients with Underlying Diseases: A Retrospective Cohort Study of 196 Cases |
title_fullStr | Percutaneous Transforaminal Endoscopic Surgery (PTES) for Treatment of Lumbar Degenerative Disease in Patients with Underlying Diseases: A Retrospective Cohort Study of 196 Cases |
title_full_unstemmed | Percutaneous Transforaminal Endoscopic Surgery (PTES) for Treatment of Lumbar Degenerative Disease in Patients with Underlying Diseases: A Retrospective Cohort Study of 196 Cases |
title_short | Percutaneous Transforaminal Endoscopic Surgery (PTES) for Treatment of Lumbar Degenerative Disease in Patients with Underlying Diseases: A Retrospective Cohort Study of 196 Cases |
title_sort | percutaneous transforaminal endoscopic surgery (ptes) for treatment of lumbar degenerative disease in patients with underlying diseases: a retrospective cohort study of 196 cases |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10072145/ https://www.ncbi.nlm.nih.gov/pubmed/37025953 http://dx.doi.org/10.2147/JPR.S396993 |
work_keys_str_mv | AT zhoutianyao percutaneoustransforaminalendoscopicsurgeryptesfortreatmentoflumbardegenerativediseaseinpatientswithunderlyingdiseasesaretrospectivecohortstudyof196cases AT matianle percutaneoustransforaminalendoscopicsurgeryptesfortreatmentoflumbardegenerativediseaseinpatientswithunderlyingdiseasesaretrospectivecohortstudyof196cases AT guyutong percutaneoustransforaminalendoscopicsurgeryptesfortreatmentoflumbardegenerativediseaseinpatientswithunderlyingdiseasesaretrospectivecohortstudyof196cases AT zhangliang percutaneoustransforaminalendoscopicsurgeryptesfortreatmentoflumbardegenerativediseaseinpatientswithunderlyingdiseasesaretrospectivecohortstudyof196cases AT chewu percutaneoustransforaminalendoscopicsurgeryptesfortreatmentoflumbardegenerativediseaseinpatientswithunderlyingdiseasesaretrospectivecohortstudyof196cases AT wangyichao percutaneoustransforaminalendoscopicsurgeryptesfortreatmentoflumbardegenerativediseaseinpatientswithunderlyingdiseasesaretrospectivecohortstudyof196cases |